Header Logo

Connection

CAROLINA GUTIERREZ to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications CAROLINA GUTIERREZ has written about Drug Administration Schedule.
CAROLINA GUTIERREZ
Connection Strength
0.018
Drug Administration Schedule
  1. Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006. J Clin Oncol. 2013 May 10; 31(14):1726-31.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.